Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
Article in Blood Advances (May 2024)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Article in Blood Advances (May 2024)
Article in Frontiers in Immunology (April 2024)
Article in Blood (March 2024)